TSVT(Delisted)
2seventy bioยทNASDAQ
--
--(--)
TSVT fundamentals
2seventy bio (TSVT) released its earnings on May 7, 2025: revenue was 22.94M (YoY +85.00%), beat estimates; EPS was 0.01 (YoY +100.99%), beat estimates.
Revenue / YoY
22.94M
+85.00%
EPS / YoY
0.01
+100.99%
Report date
May 7, 2025
EPS
Revenue
Revenue & Expenses
TSVT has released its 2025 Q1 earnings report, with revenue of 22.94M, reflecting a YoY change of 84.46%, and net profit of 482.00K, showing a YoY change of 100.92%. The Sankey diagram below clearly presents TSVT's revenue sources and cost distribution.
Key Indicators
2seventy bio (TSVT) key financial stats and ratios, covering profitability, financial health, and leverage.
2seventy bio (TSVT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
2seventy bio (TSVT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
2seventy bio (TSVT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does 2seventy bio (TSVT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track 2seventy bio (TSVT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
